J. Dobkin

724 total citations
24 papers, 556 citations indexed

About

J. Dobkin is a scholar working on Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, J. Dobkin has authored 24 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in J. Dobkin's work include Neuroscience and Neuropharmacology Research (7 papers), Respiratory and Cough-Related Research (5 papers) and Pediatric health and respiratory diseases (3 papers). J. Dobkin is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Respiratory and Cough-Related Research (5 papers) and Pediatric health and respiratory diseases (3 papers). J. Dobkin collaborates with scholars based in United States and Israel. J. Dobkin's co-authors include Peter V. Dicpinigaitis, Joseph Reichel, Paula M. Fracasso, David Piwnica-Worms, Gary D. Luker, Khalid Rauf, Thomas K. Aldrich, Ranan Rimón, Robert H. Belmaker and Joseph Biederman and has published in prestigious journals such as Science, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

J. Dobkin

24 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Dobkin United States 11 320 259 99 85 73 24 556
Lueder Fels Germany 7 114 0.4× 275 1.1× 23 0.2× 53 0.6× 21 0.3× 11 466
Kuldeep K. Vaswani United States 16 201 0.6× 112 0.4× 138 1.4× 210 2.5× 77 1.1× 37 727
Faiq J. Al-Bazzaz United States 14 319 1.0× 203 0.8× 108 1.1× 292 3.4× 17 0.2× 26 664
Michiyo Yamano Japan 13 54 0.2× 110 0.4× 162 1.6× 172 2.0× 45 0.6× 79 772
J. A. Steiner United Kingdom 11 149 0.5× 355 1.4× 64 0.6× 57 0.7× 10 0.1× 23 749
Chun‐Chia Chen Taiwan 8 64 0.2× 95 0.4× 26 0.3× 143 1.7× 50 0.7× 9 403
Hani Rashed United States 16 33 0.1× 195 0.8× 50 0.5× 154 1.8× 47 0.6× 48 707
Judith A. Nolan United Kingdom 10 117 0.4× 100 0.4× 95 1.0× 161 1.9× 17 0.2× 18 665
RF Coburn United States 8 117 0.4× 218 0.8× 160 1.6× 253 3.0× 12 0.2× 11 511

Countries citing papers authored by J. Dobkin

Since Specialization
Citations

This map shows the geographic impact of J. Dobkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Dobkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Dobkin more than expected).

Fields of papers citing papers by J. Dobkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Dobkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Dobkin. The network helps show where J. Dobkin may publish in the future.

Co-authorship network of co-authors of J. Dobkin

This figure shows the co-authorship network connecting the top 25 collaborators of J. Dobkin. A scholar is included among the top collaborators of J. Dobkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Dobkin. J. Dobkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khulan, Batbayar, Kenny Ye, Miao Shi, et al.. (2025). Normal bronchial field basal cells show persistent methylome-wide impact of tobacco smoking, including in known cancer genes. Epigenetics. 20(1). 2466382–2466382. 1 indexed citations
2.
Shi, Miao, Batbayar Khulan, Aditi Desai, et al.. (2024). Distinctive field effects of smoking and lung cancer case-control status on bronchial basal cell growth and signaling. Respiratory Research. 25(1). 317–317. 3 indexed citations
3.
Spivack, Simon D., Miao Shi, J. Dobkin, et al.. (2019). P1.11-11 Initial Discovery of Exhaled Small Polar Energetics-Related Metabolites by GC-MS for Lung Cancer Risk Assessment. Journal of Thoracic Oncology. 14(10). S519–S519. 4 indexed citations
4.
Spivack, Simon D., Miao Shi, J. Dobkin, et al.. (2019). Exhaled Small, Polar, Energetics-Related Metabolites by GC-MS for Lung Cancer Risk Assessment. A5816–A5816. 1 indexed citations
5.
Dobkin, J., et al.. (2012). A Rare Cause Of Pleural Effusion. A5191–A5191. 1 indexed citations
6.
Lehrman, Stuart G., et al.. (2002). Primary Pulmonary Hypertension and Cor Pulmonale. Cardiology in Review. 10(5). 265–278. 7 indexed citations
7.
Dicpinigaitis, Peter V., J. Dobkin, & Joseph Reichel. (2002). Antitussive Effect of the Leukotriene Receptor Antagonist Zafirlukast in Subjects with Cough-Variant Asthma*. Journal of Asthma. 39(4). 291–297. 132 indexed citations
8.
Lehrman, Stuart G., et al.. (2001). Primary pulmonary hypertension.. PubMed. 2(6). 422–30. 5 indexed citations
9.
Dicpinigaitis, Peter V. & J. Dobkin. (1999). Effect of Zafirlukast on Cough Reflex Sensitivity in Asthmatics. Journal of Asthma. 36(3). 265–270. 22 indexed citations
10.
Dicpinigaitis, Peter V. & J. Dobkin. (1998). Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects. Journal of Allergy and Clinical Immunology. 102(3). 521–522. 5 indexed citations
11.
Dicpinigaitis, Peter V., J. Dobkin, Khalid Rauf, & Thomas K. Aldrich. (1998). Inhibition of Capsaicin‐Induced Cough by the γ‐Aminobutyric Acid Agonist Baclofen. The Journal of Clinical Pharmacology. 38(4). 364–367. 50 indexed citations
12.
Dicpinigaitis, Peter V. & J. Dobkin. (1997). Antitussive Effect of the GABA-Agonist Baclofen. CHEST Journal. 111(4). 996–999. 83 indexed citations
13.
Dicpinigaitis, Peter V., J. Dobkin, & Khalid Rauf. (1997). Comparison of the Antitussive Effects of Codeine and the GABA-Agonist Baclofen. Clinical Drug Investigation. 14(4). 326–329. 10 indexed citations
14.
Dicpinigaitis, Peter V. & J. Dobkin. (1996). Effect of Angiotensin‐Converting Enzyme Inhibition on Bronchial Responsiveness. The Journal of Clinical Pharmacology. 36(4). 361–364. 6 indexed citations
15.
Lichtshtein, David, J. Dobkin, Richard P. Ebstein, et al.. (1978). Gamma-Aminobutyric Acid (GABA) in the CSF of Schizophrenic Patients Before and After Neuroleptic Treatment. The British Journal of Psychiatry. 132(2). 145–148. 50 indexed citations
16.
Dobkin, J., et al.. (1978). ELEVATION OF 7‐AMINOBUTYRYLCHOLINE CONTENT IN CAT CEREBRAL CORTEX BY ELECTRICAL STIMULATION OF AFFERENT NERVES. Journal of Neurochemistry. 30(6). 1461–1465. 2 indexed citations
17.
Dobkin, J.. (1972). EFFECTS OF EXCITATION AND ANAESTHESIA ON THE GLUTAMINE CONTENT OF THE RAT BRAIN WITH A REFERENCE TO THE ADMINISTRATION OF GLUTAMINE. Journal of Neurochemistry. 19(4). 1195–1202. 6 indexed citations
18.
Dobkin, J., et al.. (1970). A NEW PROCEDURE FOR THE MEASUREMENT OF ACID‐SOLUBLE GLUTAMINE OF TISSUE WITH PARTICULAR REFERENCE TO THE BRAIN. Journal of Neurochemistry. 17(2). 231–235. 8 indexed citations
20.
Geiger, A., J. Dobkin, & J. Magnes. (1953). Accumulation of Acid-Soluble Nitrogen in the, Brain Cortex of Cats During Stimulation. Science. 118(3074). 655–657. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026